SCHEDULE: Millennium Entities Disclose 4.4% Cryoport Stake

Millennium Management and affiliated entities have disclosed a 4.4% passive beneficial ownership stake in Cryoport, Inc. as of June 30, 2025.

Summary

• Integrated Core Strategies (US) LLC, Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander are the reporting persons.
• The reporting persons collectively beneficially own 2,212,571 shares of Cryoport, Inc. Common Stock.
• This ownership represents 4.4% of Cryoport, Inc.'s outstanding common stock.
• All reporting persons share both voting and dispositive power over the 2,212,571 shares.
• The filing is an Amendment No. 2 to a Schedule 13G, indicating an update to a previously reported passive stake.
• The securities were acquired and are held for investment purposes, not for the purpose of changing or influencing the control of Cryoport, Inc.

Sentiment

Score: 5

Explanation: The filing is a neutral, factual disclosure of beneficial ownership, typical for a Schedule 13G. It does not contain positive or negative operational news.

Risks

• The filing explicitly states the securities were not acquired or held for the purpose of changing or influencing control of the issuer, which mitigates the risk of activist investor intervention.

Future Outlook

NA

Management Comments

• The securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under Rule 14a-11.

Industry Context

This filing indicates a significant passive investment by a major hedge fund group (Millennium Management) in Cryoport, a company operating in the specialized biopharma logistics sector. Such investments can signal institutional interest in the company's long-term prospects within its niche.

Comparison to Industry Standards

• Not applicable as this filing is a beneficial ownership disclosure, not a performance or operational report.

Stakeholder Impact

• Shareholders: Provides transparency regarding significant institutional ownership, potentially signaling confidence from a major investment firm.

Key Dates

Keywords

Cryoport, Millennium Management, Integrated Core Strategies, Israel A. Englander, Schedule 13G, Beneficial Ownership, Passive Investment, Biopharma Logistics, Life Sciences